Capital Fund Management (CFM)’s Iovance Biotherapeutics IOVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-181,074
Closed -$494K 2429
2025
Q4
$494K Sell
181,074
-120,004
-40% -$278K ﹤0.01% 2221
2025
Q3
$653K Sell
301,078
-73,835
-20% -$174K 0.01% 2238
2025
Q2
$645K Sell
374,913
-224,958
-38% -$560K 0.01% 2139
2025
Q1
$2M Buy
599,871
+409,688
+215% +$2.11M 0.03% 1420
2024
Q4
$1.41M Sell
190,183
-224,490
-54% -$2.08M 0.01% 1644
2024
Q3
$3.89M Buy
414,673
+31,413
+8% +$298K 0.04% 1140
2024
Q2
$3.07M Buy
+383,260
New +$4.11M 0.03% 1191
2023
Q4
Sell
-219,973
Closed -$1M 2345
2023
Q3
$1M Sell
219,973
-52,657
-19% -$344K 0.01% 1646
2023
Q2
$1.92M Sell
272,630
-162,616
-37% -$1.16M 0.03% 1203
2023
Q1
$2.66M Sell
435,246
-102,496
-19% -$707K 0.05% 969
2022
Q4
$3.44M Buy
537,742
+437,434
+436% +$3.42M 0.08% 760
2022
Q3
$961K Buy
+100,308
New +$1.16M 0.02% 1102

Other funds holding IOVA